Slope of Hope Blog Posts

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.

Right on the Home Page

By -

As we complete our first trading week with the new site, I wanted to make clear what is perhaps the most valuable tip of all: if you click at the top of any menu (that is, the menu header itself), it will instantly whisk you away to that section. This is such a handy tip that I’ve put it front and center, right there on the homepage, permanently.

Designing the site in such a way as to “bury” the blog one level deeper was a very deliberate choice, because I wanted to force people out of their rut and explore other aspects of the site. It seems to be working, as SocialTrade and SlopeCharts use is climbing every day. However, I wanted to be clear that, for those of you who want to zip right to a specific place, this is one good way to do it.

Momentum Stocks Moving on Earnings

By -

Preface from Tim: one “bullish breakout” I really like is SlopeCharts usage (shown below), which has been steadily climbing since we launched the new site last weekend. Please note clicking on any of the hyperlinks in this post will bring up its chart, and also remember that preceding a ticker symbol with a “$” in the comments section (example: $FB) will provide a hyperlink in the same manner.

Here are five momentum stocks making a move primarily on earnings.

Arrowhead Pharmaceuticals, Inc. (ARWR) jumped $1.25 to $9.00 on 5.6 million shares Wednesday, almost four times its average volume. The drug developer reported fiscal second quarter earnings on Tuesday that matched Wall Street expectations.  The move broke the stock out of a two-month coiling consolidation.  At its intraday high of $9.60, the stock got up to resistance at the rising trendline before backing off.  A breakthrough there could lead to $13.

(more…)

Do NOT follow this link or you will be banned from the site!